Factbox: Drugmakers under pressure as China hardens reforms
HONG KONG (Reuters) - A renewed push by the central government to expand healthcare reforms and restrict costs for end users is putting pressure on margins for a growing number of Chinese drugmakers. Below are some Chinese drugmakers that have issued profit warnings in recent weeks: -- In January, Wuyi International Pharmaceutical Co Ltd, which makes medical devices for cancer, respiratory and cardiovascular diseases, said it expected a decline in net profit for 2011 despite improved turnover in the second half because of challenges from state policies and market pressure. ... read more..
source:http://yhoo.it/xPNzP5
No comments:
Post a Comment